Intensive Diet and Physical Activity on Diabetes
IDEATE
Effect of Intermittent Intensive Diet Intervention and Enhanced Physical Activity on Glycemic Control in Patients With Newly Diagnosed Type 2 diabEtes (IDEATE)
1 other identifier
interventional
326
1 country
1
Brief Summary
It is a multicenter, open-label, parallel-group, randomized controlled clinical trial, which is designed to enroll newly diagnosed type 2 diabetes patients with overweight or obesity. The patients are randomized to an intensive diet intervention (intermittent very-low -calorie diet), enhanced physical activity intervention (high-intensity interval training exercise prescription combined with resistance training) or standard education group (diabetes health education only, including lifestyle education and guidance) for 12 weeks. This trial will test the primary hypothesis of whether an intensive lifestyle treatment (diet or physical activity) is more effective than a standard education in glycemic control. The secondary hypotheses are to compare the intensive lifestyle treatment with a standard education on adipose distribution, metabolic parameters, metabolic molecules, Framingham Risk Scores, and quality of life, et al.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 6, 2019
CompletedStudy Start
First participant enrolled
January 7, 2019
CompletedFirst Posted
Study publicly available on registry
February 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 17, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 21, 2026
CompletedFebruary 12, 2026
February 1, 2026
2.4 years
January 6, 2019
February 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
change in HbA1C level (%)
12 weeks
Secondary Outcomes (16)
change in HbA1C level (%)
From enrollment to the end of follow-up at 5 years
proportion of reversal of diabetes
From enrollment to the end of follow-up at 5 years
reduction in the dosage of hypoglycemic drugs
From enrollment to the end of follow-up at 5 years
change in insulin sensitivity
From enrollment to the end of follow-up at 5 years
change in islet β-cell function
From enrollment to the end of follow-up at 5 years
- +11 more secondary outcomes
Study Arms (3)
intensive diet intervention group
EXPERIMENTALThe participants will be instructed to restrict the total daily calorie intake to 800 kcal by receiving the very-low-calorie meal replacement formula for 2 consecutive days per week. They will be allowed to maintain their normal diet in the remaining 5 days, but need to restrict total intake to 2000 kcal per day.
Enhanced physical activity group
EXPERIMENTALthe participants will take high-intensity exercise in accordance with High Intensity Interval Training (HIIT) prescriptions, with maximum heart rate and relative maximal oxygen uptake monitored. They will take both aerobic and resistance training exercise consecutively, and total training time will be expected to reach at least 150 minutes per week.
Standard education group
EXPERIMENTALthe participants will receive no extra intervention but diabetes health education, which will be carried out in large classrooms, in groups, and over the telephone. The education is mainly consisted of instructions on healthy diet and exercise plans, prevention for acute and chronic complications and self-glycemic monitoring.
Interventions
the participants will be instructed to restrict the total daily calorie intake to 800 kcal by receiving the very-low-calorie meal replacement formula for 2 consecutive days per week. They will be allowed to maintain their normal diet in the remaining 5 days, but need to restrict total intake to 2000 kcal per day.
the participants will receive no extra intervention but diabetes health education, which will be carried out in large classrooms, in groups, and over the telephone. The education is mainly consisted of instructions on healthy diet and exercise plans, prevention for acute and chronic complications and self-glycemic monitoring.
the participants will take high-intensity exercise in accordance with High Intensity Interval Training (HIIT) prescriptions, with maximum heart rate and relative maximal oxygen uptake monitored. They will take both aerobic and resistance training exercise consecutively, and total training time will be expected to reach at least 150 minutes per week.
Eligibility Criteria
You may qualify if:
- Men and women aged 40-70 years;
- Newly diagnosed type 2 diabetes
- Duration of type 2 diabetes ≤ 2 years;
- Antidiabetic treatment maintained for at least 6 weeks before recruitment;
- %≤ HbA1c \< 9.0%;
- Kg/m2 ≤ Body mass index (BMI) \<40 Kg/m2;
You may not qualify if:
- History consistent with type 1 diabetes;
- Insulin treatment;
- Severe cardiovascular disease:
- current angina
- myocardial infarction within last six months
- heart failure
- symptomatic periphery vascular disease
- Uncontrolled hypertension: systolic blood pressure \> 180 mmHg or diastolic blood pressure \> 100 mmHg;
- Myocardial ischemia indicated by resting ECG;
- Foot ulcers, peripheral neuropathy or skeletal disorders;
- Taking high intensity exercise more than 75 minutes or moderate intensity exercise more than 150 minutes per week during the screening phase
- Average weekly alcohol intake \>140 grams for men and \>70 grams for women;
- ALT or AST levels more than twice the upper limit of the normal range or active liver diseases;
- eGFR \<60 ml/min/1.73 m2, or serum creatinine \>1.5 mg/dl for men or 1.3mg/dl for women; or Proteinuria
- Malignant tumor in active-stage, or in remission stage but less than 5 years from the most recent treatment
- +15 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ruijin hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
Study Officials
- PRINCIPAL INVESTIGATOR
Guang Ning, MD, PhD
Shanghai Jiao Tong University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 6, 2019
First Posted
February 15, 2019
Study Start
January 7, 2019
Primary Completion
June 17, 2021
Study Completion
March 21, 2026
Last Updated
February 12, 2026
Record last verified: 2026-02